Trademark: 87074832
Word
ONCOEXPRESS
Status
Registered
Status Code
700
Status Date
Tuesday, January 8, 2019
Serial Number
87074832
Registration Number
5649690
Registration Date
Tuesday, January 8, 2019
Mark Type
4000
Filing Date
Friday, June 17, 2016
Published for Opposition
Tuesday, April 11, 2017

Trademark Owner History
Crown Bioscience, Inc. - Original Registrant

Classifications
9 Downloadable software in the nature of a mobile application for searching for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models; computer application software for searching for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models., namely, software for searching for genomic, pharmaceutical, histological, clinical and other data; computer software for searching for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models that may be downloaded from a global computer network; downloadable mobile applications for searching for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models; downloadable software in the nature of a mobile application for searching for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models
44 Providing a website featuring information about health and wellness, namely, genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models; providing a website featuring information about health, namely, hepatitis awareness, diagnosis and information about screening and treatment; providing a website featuring information about health, wellness and nutrition; providing a website featuring information concerning alternative health and healing; providing a website featuring information in the field of the diagnosis and treatment of Cancer and tumors; providing a website via a global computer network featuring information in the fields of health, cancer, cancer recovery and survival; providing an internet website for medical professionals and medical patients featuring medical information from remote locations via devices that feed information to the website that is processed, exchanged and accessed in real-time by users; providing an internet website for medical professionals and medical patients featuring medical information from remote locations via electronic patient monitoring devices that feed in formation to the web site that can be accessed in real-time by medical professionals for purposes of monitoring and diagnosing medical conditions
42 Providing a website featuring a search engine for searching for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models; providing a website featuring non-downloadable software for searching for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models; providing a website featuring on-line non-downloadable software that enables users to search for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models; Providing a website featuring technology that enables users to search for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models; Providing a website for the electronic storage of genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models; providing a website that gives computer users the ability to search for genomic, pharmaceutical, histological, clinical and other data of Patient derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models; providing a members-only website featuring technology which provides members with the ability to search for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models; providing a secured-access, members only website featuring technology that gives members the ability to search for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models; providing a web site featuring temporary use of non-downloadable software for searching for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models; Providing a website featuring on-line non-downloadable software that enables users to search for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models; Providing a website featuring resources, namely, a website featuring primarily non-downloadable software for searching for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models and also featuring nondownloadable publications in the nature of genomic, pharmaceutical, histological and clinical journals in the field of medical diagnosis and treatment; Providing a website featuring resources, namely, non-downloadable software for searching for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models; providing an interactive website featuring technology that allows users to search for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models; providing on-line non-downloadable software for searching for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models; providing temporary use of on-line non-downloadable software and applications for searching for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models; providing a website featuring resources, namely, a website featuring primarily non-downloadable software for searching for genomic, pharmaceutical, histological, clinical and other data of Patient-derived xenograft, human cell lines, human cell line derived xenografts, homografts of mouse tumor models, mouse cell lines, syngeneic models, and other animal models and also featuring non-downloadable publications in the nature of genomic, pharmaceutical, histological and clinical journals in the field of medical diagnosis and treatment
ONCO EXPRESS

Trademark Events
Jan 8, 2024
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Apr 28, 2021
Teas Change Of Correspondence Received
Apr 28, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 28, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 8, 2019
Registered-Principal Register
Dec 5, 2018
Notice Of Acceptance Of Statement Of Use E-Mailed
Dec 4, 2018
Allowed Principal Register - Sou Accepted
Nov 20, 2018
Teas/Email Correspondence Entered
Nov 20, 2018
Correspondence Received In Law Office
Nov 16, 2018
Assigned To Lie
Nov 6, 2018
Teas Response To Office Action Received
Jun 28, 2018
Notification Of Non-Final Action E-Mailed
Jun 28, 2018
Non-Final Action E-Mailed
Jun 28, 2018
Su - Non-Final Action - Written
Jun 25, 2018
Statement Of Use Processing Complete
Jun 5, 2018
Use Amendment Filed
Jun 25, 2018
Case Assigned To Intent To Use Paralegal
Jun 5, 2018
Teas Statement Of Use Received
Dec 7, 2017
Notice Of Approval Of Extension Request E-Mailed
Dec 5, 2017
Sou Extension 1 Granted
Dec 5, 2017
Sou Extension 1 Filed
Dec 5, 2017
Sou Teas Extension Received
Jun 6, 2017
Noa E-Mailed - Sou Required From Applicant
Apr 11, 2017
Official Gazette Publication Confirmation E-Mailed
Apr 11, 2017
Published For Opposition
Mar 22, 2017
Notification Of Notice Of Publication E-Mailed
Mar 6, 2017
Law Office Publication Review Completed
Mar 1, 2017
Approved For Pub - Principal Register
Feb 24, 2017
Data Modification Completed
Feb 23, 2017
Teas/Email Correspondence Entered
Feb 23, 2017
Correspondence Received In Law Office
Feb 20, 2017
Assigned To Lie
Feb 7, 2017
Teas Response To Office Action Received
Aug 11, 2016
Notification Of Non-Final Action E-Mailed
Aug 11, 2016
Non-Final Action E-Mailed
Aug 11, 2016
Non-Final Action Written
Aug 4, 2016
Assigned To Examiner
Jun 23, 2016
Notice Of Pseudo Mark E-Mailed
Jun 22, 2016
New Application Office Supplied Data Entered
Jun 21, 2016
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24